Prognostic significance of serum γ-glutamyltransferase in patients with advanced urothelial carcinoma

Cancer statistics, 2018

Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2018 · 17K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration

Douglas G. Altman, Lisa M. McShane, Willi Sauerbrei et al. · PLoS Medicine · 2012 · 1K citations · Full text

Medicine, Biostatistics, Oncology +13

Long-Term Survival in Metastatic Transitional-Cell Carcinoma and Prognostic Factors Predicting Outcome of Therapy

Dean F. Bajorin, Paul M. Dodd, Madhu Mazumdar et al. · Journal of Clinical Oncology · 1999 · 729 citations

Medicine, Biostatistics, Oncology +14

Randomized Phase III Study Comparing Paclitaxel/Cisplatin/ Gemcitabine and Gemcitabine/Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Cancer Without Prior Systemic Therapy: EORTC Intergroup Study 30987

Joaquim Bellmunt, Hans von der Maase, Graham M. Mead et al. · Journal of Clinical Oncology · 2012 · 535 citations · Full text

Medicine, Oncology, Pharmacology +12

Gamma-glutamyltransferase of cancer cells at the crossroads of tumor progression, drug resistance and drug targeting.

Alessandro Corti, Maria Franzini, Aldo Paolicchi et al. · PubMed · 2010 · 232 citations

Life Sciences, Cancer Biology, Oncology +17